MT-1186
MT-1186-A04
Phase 3 small_molecule terminated
Quick answer
MT-1186 for ALS is a Phase 3 program (small_molecule) at Tanabe Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Tanabe Pharma
- Indication
- ALS
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- terminated